Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice volume today... we may see another filing before Christmas... ho..ho...ho...
I’m aware... here since 2014... just color between the lines enough..
Good call... just like the SunGen partnership is a flop... Oh wait...!!!
Elites valuation probably doubled today.. far exceeding the 7% climb in the PPS... LOL LOL
Yes bad day for Elite... probably doubled the value of the company ( insert sarcasm)
Nice Moose.. let’s head NORTH...
$750,000 milestone payment from Lannett upon approval.
Merry Christmas Ted... and congrats... more approvals and filings on the way.
Looking forward to year end financials. Nasrat talked about the “going concern” being removed then also. It has to stay until the year end financials.
Milestone from Lannett triggered. Revenue starting to flow in with new manufacturing fees due. Future is very bright indeed.
Congrats Chasing, yes no CRL’s and SunGen partnership being a flop is debunked.
Missing all the CEO bashing today lol... now they will only blame Nasrat for the share price..haha...
Same to you YJ.... it’s been a tremendous turn around for this company... We know what we own...
Yes I agree... buyers just waiting
Let us not be fooled with the PPS and where it may end up today... Penny flippers will have a field day on a few ticks here and there.
ELTP future is bright.. When the revenues start to flow in we will get back to the true value of this company.
At the shareholders meeting Nasrat said the FDA asked for more info.. Not due until March now
Congrats to all
Sold tells the story better.. thank you
Hey Nas... could you remove Percocet and Norco from your chart so newbies won’t be confused?.. thanks
A nice explanation of CRL’s here... good read..
Any uptick in the CRLs that deal with chemistry, manufacturing, and controls issues is really a function of increased focus by the agency on drug manufacturing, particularly of foreign firms,” he says. “Like anything, if you put more microscopes on a problem, you are going to find more issues.”
The agency doesn’t release CRLs publicly because of confidentiality concerns, and most companies disclose only limited details. “Whether and how a company discloses why it got its CRL really depends on the company,” Cormier says.
“Most publicly traded companies will disclose that information because they have U.S. Securities & Exchange Commission obligations to disclose material facts to their shareholders,” he says. “Small companies that often are privately held may be less likely to make public that they even got a CRL and, if they go that far, the ‘why’ behind it.”
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwj-ocT2tKvmAhUthOAKHdyPAswQFjAAegQIBRAB&url=https%3A%2F%2Fcen.acs.org%2Farticles%2F95%2Fi20%2Fcomplete-response-letter-mail-one.html&usg=AOvVaw1ghhBsx0ttSnEnvcN9wNBK
Great read... thank you StategyDoc...for getting the word out there.
JGD... Nasrat also used a PE of 20-25 in his calculations when talking about uplisting at the shareholders meeting.. You are spot on.
We’ll see what the next 10 trading days says about that.
This is fair... IMO they are definitely understaffed and inexperienced in areas. But, with all the shortcomings. They are about to become a big player in the CNS Pharma business.
Great question... and no that never got asked... but my guess just from personal observation is... Nasrat keeps it very tight.. I believe they are very stretched with personnel. IMO... not sure if that is a reason or just more likely the FDA just wanted more.
Nasrat did say the DEA is being very hard line with narcotics..
This is BS ....I believe Nasrat said at the shareholders meeting that the government issued quotas... have to be bid on. So there’s that. Glad I could clear up the confusion.
Question was asked about the pace of the FDA... Nasrat said, “ I don’t believe in conspiracy theories ...but sometimes we ask the FDA for some guidance. Maybe a question that can be answered in 5 minutes he said. Then it’s six months later when the FDA gets back to you” it’s just how the FDA works.
No Jimmy, was there with my two brothers. Was focused on meeting Nasrat, Carter, Dianne and I got to meet Jerry.
Welcome to the board. Yes Nasrat seemed very committed to advancing Elite forward as quickly as possible.
Again as focused as we all are on our future with this company. I think it is important to reflect back on what we have been through in the last 5-6 years and where we would be if we stay strictly focused on the anti abuse pipeline. Would we be buried in law suits?.... Would we be bankrupt?
Instead we are coming of back to back very successful quarters with the best yet to come with a couple of huge approvals coming and a couple of huge filings coming.
The SunGen ER Nas.. ready to go by February maybe January were his exact words.
Haha.. I completely forgot about the mugs.. Well like I said .. Nasrat is very frugal lol
Almost all out of posts for the day.. GLTA
Yes bubba were you on the end..?.. What’s your take on the meeting?
Yes I got it.. Long drive for you two
Same here. I was there with my brothers. Good things are coming... It just takes so much time.
I also missed Nasrat’s response to the antibiotics ANDA but my brothers heard it.
So hard to take in everything yourself.
Nasrat named four or five pharmaceutical’s that are currently bankrupted or soon to be because of the political climate for opioid. Again Elite has pivoted in another direction.. instead of staying the course and going bankrupt also. I tip my hat to that.But not here to change anyone’s mind.
IMO Nasrat is extremely frugal with Elite’s cash on hand and shares. Also with Elite’s facilities and employees. He talked a lot about producing products with high profits instead of high volume products that yield less profits and puts strain on resources.
That question got asked and Nasrat said he thought it would take 50 million in revenue ( I think that is what I heard).. and a couple more years... I know, I know.... He also said he is constantly looking for a Merger but it has to be a win/win situation with a company that is similar to Elite.
Meeting was held in the exact place that Nasrat has lived for 5 years. Only goes home on the weekends.
3 miles from Elite headquarters and R&D facility. Which had lots of cars and activities going on.
Not enough credit is given to the CEO and board for pivoting when the opioid climate changed and regrouping with CNS products and partners. IMO...
Oh I was there. Just trying to connect some people.
Meeting was great and very up beat.
Q and A was very good. A lot of questions asked and talked about that don’t make the cut on the CC’s..
Carter Ward emphasized we are really close to profitability
FDA want more on the Antibiotic ANDA. Nasrat said sometime now before March.
Still expecting “ The Monster “ in the next few weeks ( that’s for you Nasdaq2020”
Nasrat talked about needing 50 million to get to the Nasdaq.
Elite would need 5-7 million more to continue to advance SequestOx. Which at this time they don’t have to spend. Also would not be worth the risk of law suits in this political climate.
Elite has been approached to actually purchase other company opioid products .. That they no longer what the risk of owning.
What questions did you ask?
* Hyder.... sorry
Hyderabad you were there today?
I believe good news just before the shareholders meeting is more likely
Prescription’s aren’t the reason
https://news.yahoo.com/report-prescriptions-arent-causing-opioid-031500737.html